Viemed Healthcare Announces Third Quarter 2026 Earnings Conference Call Details
Viemed Healthcare, Inc. has scheduled its third quarter 2026 earnings conference call for November 5, 2026, at 11:00 a.m. EST.
Stocks · News reference
Viemed Healthcare Raises FY2026 Sales Guidance from $312.000M-$320.000M to $314.000M-$320.000M vs $317.300M Est
Viemed Healthcare (NASDAQ:VMD) raises FY2026 sales outlook from $312.000 million-$320.000 million to $314.000 million-$320.000 million vs $317.300 million estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Reported Earlier, Viemed Healthcare's Michael Moore Adopts Year-Long ASDP Allowing Sale Of Up To 246,000 Shares Through November 30, 2027
Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures fell, with Nasdaq 100 futures down 500 points. Corning dropped 8% after a $2B offering; several other stocks also slid premarket.
Barrington Research Initiates Coverage On Viemed Healthcare with Outperform Rating, Announces Price Target of $14
Barrington Research initiates coverage on Viemed Healthcare (NASDAQ:VMD) with a Outperform rating and announces Price Target of $14.